Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992052 · ClinicalTrials.gov registry record · NA
Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT04992052 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 52 participants.
The verdict
NCT04992052, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the application of bone wax to exposed cancellous bone, after the cemented implants are in place, will provide superior hemostasis in total knee arthroplasty (TKA) patients compared to patients who do not have the bone wax applied. Hemostasis will be assessed by calculating blood loss using the Hb-balance formula.
Interventions
- DEVICE Bone wax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2023-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04992052
The ClinicalTrials.gov registry entry for NCT04992052 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone wax is the first listed.
NCT04992052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04992052 about?
NCT04992052 is a clinical study titled "Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty". The purpose of this study is to assess whether the application of bone wax to exposed cancellous bone, after the cemented implants are in place, will provide superior hemostasis in total knee arthroplasty (TKA) patients compared to patients who do not have the bone wax applied. Hemostasis will be as...
What is the current status of trial NCT04992052?
This trial is currently terminated. It is a NA study. The enrollment target is 52 participants. The study started on 2021-07-27. Estimated completion is 2023-09-12.
What interventions are being tested in trial NCT04992052?
The interventions under investigation include: Bone wax (DEVICE).
Who is sponsoring clinical trial NCT04992052?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.